{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:12:36Z","timestamp":1790161956614,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Australian Department of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.05.104","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T22:51:55Z","timestamp":1528152715000},"page":"4311-4316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study"],"prefix":"10.1016","volume":"36","author":[{"given":"Skye","family":"McGregor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Saulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.L.","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rachel","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Luey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr N.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl 2","key":"10.1016\/j.vaccine.2018.05.104_b0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","article-title":"Natural history and epidemiology of HPV infection and cervical cancer","volume":"110","author":"Castellsague","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.104_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.104_b0015","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"The Lancet Public Health."},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.104_b0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21106\/ijma.12","article-title":"Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development","volume":"1","author":"Singh","year":"2012","journal-title":"Int J MCH AIDS"},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.104_b0025","doi-asserted-by":"crossref","first-page":"e012753","DOI":"10.1136\/bmjopen-2016-012753","article-title":"Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE)","volume":"6","author":"Akinyemiju","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2018.05.104_b0030","unstructured":"Australian Bureau of Statistics. Estimates of aboriginal and Torres Strait Islander Australians, June 2011 Canberra; 2013 [available from: http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/3238.0.55.001]."},{"key":"10.1016\/j.vaccine.2018.05.104_b0035","series-title":"Closing the gap prime minister\u2019s report 2017","author":"Commonwealth of Australia","year":"2017"},{"key":"10.1016\/j.vaccine.2018.05.104_b0040","series-title":"Cervical screening in Australia 2013\u20132014","author":"Australian institute of Health and Welfare","year":"2016"},{"issue":"9","key":"10.1016\/j.vaccine.2018.05.104_b0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5694\/j.1326-5377.2006.tb00663.x","article-title":"Participation in cervical screening by Indigenous women in the Northern Territory: a longitudinal study","volume":"185","author":"Binns","year":"2006","journal-title":"Med J Aust"},{"issue":"10","key":"10.1016\/j.vaccine.2018.05.104_b0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5694\/j.1326-5377.2002.tb04949.x","article-title":"Participation in cervical cancer screening by women in rural and remote Aboriginal and Torres Strait Islander communities in Queensland","volume":"177","author":"Coory","year":"2002","journal-title":"Med J Aust"},{"issue":"10","key":"10.1016\/j.vaccine.2018.05.104_b0055","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/cncr.29954","article-title":"The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: a retrospective registry cohort study in Queensland, Australia (2000\u20132011)","volume":"122","author":"Whop","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.vaccine.2018.05.104_b0060","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.104_b0065","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ijc.21953","article-title":"Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies","volume":"119","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2018.05.104_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-9-104","article-title":"Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program","volume":"9","author":"Garland","year":"2011","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.104_b0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1071\/SH09137","article-title":"Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy","volume":"7","author":"Brotherton","year":"2010","journal-title":"Sex Health"},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.104_b0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1753-6405.12218","article-title":"Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?","volume":"38","author":"Barbaro","year":"2014","journal-title":"Aust N Z J Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.104_b0085","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2018.05.104_b0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"Tabrizi","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.05.104_b0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5694\/mja13.10272","article-title":"Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach","volume":"199","author":"Brotherton","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2018.05.104_b0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-13-140","article-title":"Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program","volume":"13","author":"Ali","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.104_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"Smith","year":"2015","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.104_b0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5694\/mja16.00597","article-title":"Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data","volume":"206","author":"Ali","year":"2017","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.104_b0115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2013.11.075","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","volume":"32","author":"Brotherton","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.104_b0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jviromet.2007.09.018","article-title":"Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system","volume":"147","author":"Stevens","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.05.104_b0125","unstructured":"Australian Bureau of Statistics. Remoteness structure 2014 [updated 10 June 2014. Available from: http:\/\/www.abs.gov.au\/websitedbs\/D3310114.nsf\/home\/remoteness+structure."},{"key":"10.1016\/j.vaccine.2018.05.104_b0130","doi-asserted-by":"crossref","unstructured":"I. Heard L. Tondeur L. Arowas M. Demazoin M. Falguieres I. Parent Du Chatelet Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France J Infect Dis 2016","DOI":"10.1093\/infdis\/jiw639"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.104_b0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.05.104_b0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","article-title":"Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009\u20132013","volume":"22","author":"Cameron","year":"2016","journal-title":"Emerg Infect Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.104_b0145","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","author":"Kavanagh","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2018.05.104_b0150","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy075","article-title":"Very low prevalence of vaccine human papillomavirus (HPV) types among 18\u201335 year old Australian women, nine years following implementatin of vaccination","author":"Machalek","year":"2018","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.05.104_b0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5694\/mja16.00820","article-title":"The renewal of the national cervical screening program","volume":"205","author":"Carter","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2018.05.104_b0160","article-title":"Human papillomavirus vaccines: WHO position paper May 2017 \u2013 Recommendations","author":"WH Organization","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:41Z","timestamp":1759400861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18307710"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}